487 related articles for article (PubMed ID: 21107100)
1. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.
Huang J; Yan L; Cheng Z; Wu H; Du L; Wang J; Xu Y; Zeng Y
Ann Surg; 2010 Dec; 252(6):903-12. PubMed ID: 21107100
[TBL] [Abstract][Full Text] [Related]
2. Role of radiofrequency ablation in the treatment of small hepatocellular carcinoma.
Zhang YJ; Chen MS
World J Hepatol; 2010 Apr; 2(4):146-50. PubMed ID: 21160987
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma.
Feng K; Yan J; Li X; Xia F; Ma K; Wang S; Bie P; Dong J
J Hepatol; 2012 Oct; 57(4):794-802. PubMed ID: 22634125
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma.
Ng KKC; Chok KSH; Chan ACY; Cheung TT; Wong TCL; Fung JYY; Yuen J; Poon RTP; Fan ST; Lo CM
Br J Surg; 2017 Dec; 104(13):1775-1784. PubMed ID: 29091283
[TBL] [Abstract][Full Text] [Related]
5. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinomas: a meta-analysis of randomized and nonrandomized controlled trials.
Wang Y; Luo Q; Li Y; Deng S; Wei S; Li X
PLoS One; 2014; 9(1):e84484. PubMed ID: 24404166
[TBL] [Abstract][Full Text] [Related]
6. Management of hepatocellular carcinoma: an update.
Bruix J; Sherman M;
Hepatology; 2011 Mar; 53(3):1020-2. PubMed ID: 21374666
[No Abstract] [Full Text] [Related]
7. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma.
;
J Hepatol; 2012 Apr; 56(4):908-43. PubMed ID: 22424438
[No Abstract] [Full Text] [Related]
8. Comparison of long-term effectiveness and complications of radiofrequency ablation with hepatectomy for small hepatocellular carcinoma.
Fang Y; Chen W; Liang X; Li D; Lou H; Chen R; Wang K; Pan H
J Gastroenterol Hepatol; 2014 Jan; 29(1):193-200. PubMed ID: 24224779
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma.
Cucchetti A; Piscaglia F; Cescon M; Colecchia A; Ercolani G; Bolondi L; Pinna AD
J Hepatol; 2013 Aug; 59(2):300-7. PubMed ID: 23603669
[TBL] [Abstract][Full Text] [Related]
10. Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria.
Liu H; Wang ZG; Fu SY; Li AJ; Pan ZY; Zhou WP; Lau WY; Wu MC
Br J Surg; 2016 Mar; 103(4):348-56. PubMed ID: 26780107
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation versus hepatic resection for the treatment of early-stage hepatocellular carcinoma meeting Milan criteria: a systematic review and meta-analysis.
Duan C; Liu M; Zhang Z; Ma K; Bie P
World J Surg Oncol; 2013 Aug; 11(1):190. PubMed ID: 23941614
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma.
Forner A; Llovet JM; Bruix J
Lancet; 2012 Mar; 379(9822):1245-55. PubMed ID: 22353262
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma: a meta-analysis of randomized controlled trials.
Qi X; Tang Y; An D; Bai M; Shi X; Wang J; Han G; Fan D
J Clin Gastroenterol; 2014; 48(5):450-7. PubMed ID: 24172183
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis.
Xu XL; Liu XD; Liang M; Luo BM
Radiology; 2018 May; 287(2):461-472. PubMed ID: 29135366
[TBL] [Abstract][Full Text] [Related]
15. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.
Bruix J; Reig M; Sherman M
Gastroenterology; 2016 Apr; 150(4):835-53. PubMed ID: 26795574
[TBL] [Abstract][Full Text] [Related]
16. Survival comparison between surgical resection and radiofrequency ablation for patients in BCLC very early/early stage hepatocellular carcinoma.
Wang JH; Wang CC; Hung CH; Chen CL; Lu SN
J Hepatol; 2012 Feb; 56(2):412-8. PubMed ID: 21756858
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors.
Shiina S; Tateishi R; Arano T; Uchino K; Enooku K; Nakagawa H; Asaoka Y; Sato T; Masuzaki R; Kondo Y; Goto T; Yoshida H; Omata M; Koike K
Am J Gastroenterol; 2012 Apr; 107(4):569-77; quiz 578. PubMed ID: 22158026
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency (thermal) ablation versus no intervention or other interventions for hepatocellular carcinoma.
Weis S; Franke A; Mössner J; Jakobsen JC; Schoppmeyer K
Cochrane Database Syst Rev; 2013 Dec; (12):CD003046. PubMed ID: 24357457
[TBL] [Abstract][Full Text] [Related]
19. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
[TBL] [Abstract][Full Text] [Related]
20. Management of people with early- or very early-stage hepatocellular carcinoma: an attempted network meta-analysis.
Majumdar A; Roccarina D; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011650. PubMed ID: 28351116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
